twenty-nine patients with systemic scleroderma ( ssd ) , whose lymphocytes significantly responded to a scleroderma-inducing glycosaminoglycan-associated antigen ( stimulation index greater than or equal to 1.7 ) , were separated into the two groups of marked and moderate responses , according to the mitogenic response of their peripheral lymphocytes .
C0036421
systemic scleroderma
C0011644
scleroderma